Prolong

CHIEF MEDICAL OFFICER

Dr. Kirsten Gruis

Dr. Gruis is the Chief Medical Officer at Prolong Pharmaceuticals, with over 15 years of experience in academia, pharmaceuticals, and biotechnology. She has previously served as CMO at DiaMedica Therapeutics, Edgewise Therapeutics, and Agilis Biotherapeutics, overseeing clinical development and leading FDA and EMA filings. Dr. Gruis holds an M.D. from the University of Iowa and a Master's in Clinical Trial Design from the University of Michigan.

Experience

•Served as CMO at DiaMedica Therapeutics, Edgewise Therapeutics, Agilis Biotherapeutics.

•Oversaw clinical development for numerous programs across various therapeutic areas.

•Successfully led FDA and EMA filings in the US and EU.

Previous Roles

•Served as CMO at DiaMedica Therapeutics, Edgewise Therapeutics, Agilis Biotherapeutics.

•Neuromuscular Franchise Head at Roche.

Education

•Doctor of Medicine (M.D.) from University of Iowa College of Medicine.

•Masters in Clinical Trial Design and Statistical Analysis from University of Michigan, School of Public Health.

Dr. Kirsten Gruis

Learn how you can be part of the journey